GHU Logo
The Great Heights University Library
Academic discovery, digital access, and research support

BioDrugs (Record no. 3534)

MARC details
000 -LEADER
fixed length control field 02024nas a22003495i 4500
001 - CONTROL NUMBER
control field 1179-190X
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20260610082520.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 150723s||||||||sz uu poo|||||| b|EN |d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1179-190X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/40259.1179-190X
Source of number or code doi
210 10 - ABBREVIATED TITLE
Abbreviated title BioDrugs
245 10 - TITLE STATEMENT
Title BioDrugs
Medium [electronic resource] /
Statement of responsibility, etc. edited by Mike Herbert.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Cham :
Name of producer, publisher, distributor, manufacturer Springer International Publishing :
-- Imprint: Adis.
300 ## - online resource
Other physical details online resource.
520 ## - SUMMARY, ETC.
Summary, etc. BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease. The Journal includes: Definitive reviews on topics relating to the development and use of biotechnology in healthcare and the management of disease. Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. Original research articles on the clinical development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products. Leading/Current Opinion articles providing an overview of contentious or emerging issues and key regulatory and ethical issues. Adis Drug Evaluations reviewing the properties and place in therapy of biotechnology-based drugs. Adis Biosimilar Briefs summarizing key characteristics and clinical use of biosimilar drugs. .
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Medicine—Research.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biology—Research.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunospecificity.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Therapeutics.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomedical Research.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adaptive Immunity.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer Biology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Therapeutics.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Herbert, Mike.
Relator term editor.
Relationship edt
-- http://id.loc.gov/vocabulary/relators/edt
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed version:
International Standard Serial Number 1173-8804
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/40259.1179-190X">https://doi.org/10.1007/40259.1179-190X</a>
Public note Hybrid

No items available.